The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA approval awaited this month . : r biotech_stocks GHK Cu 50mg Copper Peptide Research Grade Midwest Peptide FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure